{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:12:56Z","timestamp":1778551976071,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T00:00:00Z","timestamp":1396828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T00:00:00Z","timestamp":1396828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/cmi.2014.17","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T09:10:44Z","timestamp":1396861844000},"page":"377-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["\u03b11-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation"],"prefix":"10.1038","volume":"11","author":[{"given":"Avishag","family":"Abecassis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronen","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galit","family":"Shahaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Ozeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Ochayon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peleg","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli C","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,7]]},"reference":[{"key":"BFcmi201417_CR1","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s001250100021","volume":"44","author":"DL Eizirik","year":"2001","unstructured":"Eizirik DL, Mandrup-Poulsen T . A choice of death\u2014the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 2001; 44: 2115\u20132133.","journal-title":"Diabetologia"},{"key":"BFcmi201417_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1399-3089.2007.00419.x","volume":"14","author":"DJ van der Windt","year":"2007","unstructured":"van der Windt DJ, Bottino R, Casu A, Campanile N, Cooper DK . Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 2007; 14: 288\u2013297.","journal-title":"Xenotransplantation"},{"key":"BFcmi201417_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF02427283","volume":"29","author":"T Mandrup-Poulsen","year":"1986","unstructured":"Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH . Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 1986; 29: 63\u201367.","journal-title":"Diabetologia"},{"key":"BFcmi201417_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/physrev.00003.2010","volume":"91","author":"TL van Belle","year":"2011","unstructured":"van Belle TL, Coppieters KT, von Herrath MG . Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011; 91: 79\u2013118.","journal-title":"Physiol Rev"},{"key":"BFcmi201417_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2007.08.002","volume":"27","author":"CM Filippi","year":"2007","unstructured":"Filippi CM, von Herrath MG . Islet beta-cell death\u2014fuel to sustain autoimmunity? Immunity 2007; 27: 183\u2013185.","journal-title":"Immunity"},{"key":"BFcmi201417_CR6","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1007\/s001250050574","volume":"39","author":"K Yamada","year":"1996","unstructured":"Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C, Nonaka K . Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 1996; 39: 1306\u20131312.","journal-title":"Diabetologia"},{"key":"BFcmi201417_CR7","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s001250051506","volume":"43","author":"WL Suarez-Pinzon","year":"2000","unstructured":"Suarez-Pinzon WL, Power RF, Rabinovitch A . Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice. Diabetologia 2000; 43: 1149\u20131156.","journal-title":"Diabetologia"},{"key":"BFcmi201417_CR8","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1007\/s00125-012-2713-z","volume":"55","author":"P Ylipaasto","year":"2012","unstructured":"Ylipaasto P, Smura T, Gopalacharyulu P, Paananen A, Seppanen-Laakso T, Kaijalainen S et al. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction. Diabetologia 2012; 55: 3273\u20133283.","journal-title":"Diabetologia"},{"key":"BFcmi201417_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2174\/15733998113099990063","volume":"9","author":"A Ramesh","year":"2013","unstructured":"Ramesh A, Chhabra P, Brayman KL . Pancreatic islet transplantation in type 1 diabetes mellitus: an update on recent developments. Curr Diabetes Rev 2013; 9: 294\u2013311.","journal-title":"Curr Diabetes Rev"},{"key":"BFcmi201417_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1189\/jlb.1104649","volume":"77","author":"NR Barshes","year":"2005","unstructured":"Barshes NR, Wyllie S, Goss JA . Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005; 77: 587\u2013597.","journal-title":"J Leukoc Biol"},{"key":"BFcmi201417_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/jcp.21770","volume":"220","author":"A Schwarznau","year":"2009","unstructured":"Schwarznau A, Hanson MS, Sperger JM, Schram BR, Danobeitia JS, Greenwood KK et al. IL-1beta receptor blockade protects islets against pro-inflammatory cytokine induced necrosis and apoptosis. J Cell Physiol 2009; 220: 341\u2013347.","journal-title":"J Cell Physiol"},{"key":"BFcmi201417_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1189\/jlb.1104649","volume":"77","author":"NR Barshes","year":"2005","unstructured":"Barshes NR, Wyllie S, Goss JA . Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005; 77: 587\u2013597.","journal-title":"J Leukoc Biol"},{"key":"BFcmi201417_CR13","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA . Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011; 117: 3720\u20133732.","journal-title":"Blood"},{"key":"BFcmi201417_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","volume":"13","author":"WP Arend","year":"2002","unstructured":"Arend WP . The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 2002; 13: 323\u2013340.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFcmi201417_CR15","doi-asserted-by":"publisher","first-page":"e55925","DOI":"10.1371\/journal.pone.0055925","volume":"8","author":"MS Akash","year":"2013","unstructured":"Akash MS, Rehman K, Sun H, Chen S . Sustained delivery of IL-1Ra from PF127-gel reduces hyperglycemia in diabetic GK-rats. PloS ONE 2013; 8: e55925.","journal-title":"PloS ONE"},{"key":"BFcmi201417_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/jcp.21770","volume":"220","author":"A Schwarznau","year":"2009","unstructured":"Schwarznau A, Hanson MS, Sperger JM, Schram BR, Danobeitia JS, Greenwood KK et al. IL-1beta receptor blockade protects islets against pro-inflammatory cytokine induced necrosis and apoptosis. J Cell Physiol 2009; 220: 341\u2013347.","journal-title":"J Cell Physiol"},{"key":"BFcmi201417_CR17","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/dc09-0533","volume":"32","author":"CM Larsen","year":"2009","unstructured":"Larsen CM, Faulenbach M, Vaag A, Ehses JA, Donath MY, Mandrup-Poulsen T . Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 2009; 32: 1663\u20131668.","journal-title":"Diabetes Care"},{"key":"BFcmi201417_CR18","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa065213","volume":"356","author":"CM Larsen","year":"2007","unstructured":"Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356: 1517\u20131526.","journal-title":"N Engl J Med"},{"key":"BFcmi201417_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","volume":"16","author":"WP Arend","year":"1998","unstructured":"Arend WP, Malyak M, Guthridge CJ, Gabay C . Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998; 16: 27\u201355.","journal-title":"Annu Rev Immunol"},{"key":"BFcmi201417_CR20","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00125-009-1349-0","volume":"52","author":"R Glas","year":"2009","unstructured":"Glas R, Sauter NS, Schulthess FT, Shu L, Oberholzer J, Maedler K . Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival. Diabetologia 2009; 52: 1579\u20131588.","journal-title":"Diabetologia"},{"key":"BFcmi201417_CR21","doi-asserted-by":"publisher","first-page":"8138","DOI":"10.1073\/pnas.0305683101","volume":"101","author":"K Maedler","year":"2004","unstructured":"Maedler K, Sergeev P, Ehses JA, Mathe Z, Bosco D, Berney T et al. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. Proc Natl Acad Sci USA 2004; 101: 8138\u20138143.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201417_CR22","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.149.6.2000","volume":"149","author":"MF Smith Jr","year":"1992","unstructured":"Smith MF, Jr ., Eidlen D, Brewer MT, Eisenberg SP, Arend WP, Gutierrez-Hartmann A. Human IL-1 receptor antagonist promoter. Cell type-specific activity and identification of regulatory regions. J Immunol 1992; 149: 2000\u20132007.","journal-title":"J Immunol"},{"key":"BFcmi201417_CR23","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1002\/eji.1830221022","volume":"22","author":"J Andersson","year":"1992","unstructured":"Andersson J, Bjork L, Dinarello CA, Towbin H, Andersson U . Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol 1992; 22: 2617\u20132623.","journal-title":"Eur J Immunol"},{"key":"BFcmi201417_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/1043-4666(93)90030-9","volume":"5","author":"JK Jenkins","year":"1993","unstructured":"Jenkins JK, Arend WP . Interleukin 1 receptor antagonist production in human monocytes is induced by IL-1 alpha, IL-3, IL-4 and GM-CSF. Cytokine 1993; 5: 407\u2013415.","journal-title":"Cytokine"},{"issue":"1","key":"BFcmi201417_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2172-7-5","volume":"7","author":"Juergen Luhm","year":"2006","unstructured":"Luhm J, Langenkamp U, Hensel J, Frohn C, Brand JM, Hennig H et al. Beta-(1\u21923)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta\/IL-1 receptor antagonist ratio. BMC Immunol 2006; 7: 5.","journal-title":"BMC Immunology"},{"key":"BFcmi201417_CR26","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.4049\/jimmunol.176.9.5598","volume":"176","author":"Y Ishida","year":"2006","unstructured":"Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N . Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway. J Immunol 2006; 176: 5598\u20135606.","journal-title":"J Immunol"},{"key":"BFcmi201417_CR27","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.4049\/jimmunol.153.8.3584","volume":"153","author":"MF Smith Jr","year":"1994","unstructured":"Smith MF Jr, Eidlen D, Arend WP, Gutierrez-Hartmann A . LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. J Immunol 1994; 153: 3584\u20133593.","journal-title":"J Immunol"},{"key":"BFcmi201417_CR28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2119\/molmed.2011.00196","volume":"18","author":"EC Lewis","year":"2012","unstructured":"Lewis EC . Expanding the clinical indications for alpha1-antitrypsin therapy. Mol Med 2012; 18: 957\u2013970.","journal-title":"Mol Med"},{"key":"BFcmi201417_CR29","first-page":"191","volume":"138","author":"EW Russi","year":"2008","unstructured":"Russi EW . Alpha-1 antitrypsin: now available, but do we need it? Swiss Med Wkly 2008; 138: 191\u2013196.","journal-title":"Swiss Med Wkly"},{"key":"BFcmi201417_CR30","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1097\/TP.0b013e31818bdbef","volume":"86","author":"C Toso","year":"2008","unstructured":"Toso C, Serre-Beinier V, Emamaullee J, Merani S, Armanet M, Wojtusciszyn A et al. The role of macrophage migration inhibitory factor in mouse islet transplantation. Transplantation 2008; 86: 1361\u20131369.","journal-title":"Transplantation"},{"key":"BFcmi201417_CR31","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1189\/jlb.0208145","volume":"85","author":"GB Pott","year":"2009","unstructured":"Pott GB, Chan ED, Dinarello CA, Shapiro L . Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol 2009; 85: 886\u2013895.","journal-title":"J Leukoc Biol"},{"key":"BFcmi201417_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4049\/jimmunol.1101340","volume":"189","author":"E Ozeri","year":"2012","unstructured":"Ozeri E, Mizrahi M, Shahaf G, Lewis EC . alpha-1 antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells. J Immunol 2012; 189: 146\u2013153.","journal-title":"J Immunol"},{"key":"BFcmi201417_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1073\/pnas.1117665109","volume":"109","author":"I Tawara","year":"2012","unstructured":"Tawara I, Sun Y, Lewis EC, Toubai T, Evers R, Nieves E et al. Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 2012; 109: 564\u2013569.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201417_CR34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2119\/molmed.2011.00145","volume":"17","author":"G Shahaf","year":"2011","unstructured":"Shahaf G, Moser H, Ozeri E, Mizrahi M, Abecassis A, Lewis EC . alpha-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection. Mol Med 2011; 17: 1000\u20131011.","journal-title":"Mol Med"},{"key":"BFcmi201417_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11011-011-9239-9","volume":"26","author":"S Subramanian","year":"2011","unstructured":"Subramanian S, Shahaf G, Ozeri E, Miller LM, Vandenbark AA, Lewis EC et al. Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice. Metab Brain Dis 2011; 26: 107\u2013113.","journal-title":"Metab Brain Dis"},{"key":"BFcmi201417_CR36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.yjmcc.2011.05.003","volume":"51","author":"S Toldo","year":"2011","unstructured":"Toldo S, Seropian IM, Mezzaroma E, Van Tassell BW, Salloum FN, Lewis EC et al. Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 2011; 51: 244\u2013251.","journal-title":"J Mol Cell Cardiol"},{"key":"BFcmi201417_CR37","doi-asserted-by":"publisher","first-page":"e51078","DOI":"10.1371\/journal.pone.0051078","volume":"7","author":"Y Wang","year":"2012","unstructured":"Wang Y, He Y, Abraham B, Rouhani FN, Brantly ML, Scott DE et al. Cytosolic, autocrine alpha-1 proteinase inhibitor (A1PI) inhibits caspase-1 and blocks IL-1beta dependent cytokine release in monocytes. PloS ONE 2012; 7: e51078.","journal-title":"PloS ONE"},{"key":"BFcmi201417_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1164\/rccm.201108-1428CI","volume":"185","author":"JK Stoller","year":"2012","unstructured":"Stoller JK, Aboussouan LS . A review of alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2012; 185: 246\u2013259.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFcmi201417_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4161\/isl.2.3.11654","volume":"2","author":"M Kalis","year":"2010","unstructured":"Kalis M, Kumar R, Janciauskiene S, Salehi A, Cilio CM . alpha 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic beta-cells. Islets 2010; 2: 185\u2013189.","journal-title":"Islets"},{"key":"BFcmi201417_CR40","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.2337\/db06-1273","volume":"56","author":"B Zhang","year":"2007","unstructured":"Zhang B, Lu Y, Campbell-Thompson M, Spencer T, Wasserfall C, Atkinson M et al. Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes 2007; 56: 1316\u20131323.","journal-title":"Diabetes"},{"key":"BFcmi201417_CR41","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.4049\/jimmunol.1001358","volume":"186","author":"X Zhou","year":"2011","unstructured":"Zhou X, Shapiro L, Fellingham G, Willardson BM, Burton GF . HIV replication in CD4+ T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by alpha-1-antitrypsin through altered IkappaBalpha ubiquitination. J Immunol 2011; 186: 3148\u20133155.","journal-title":"J Immunol"},{"key":"BFcmi201417_CR42","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1189\/jlb.0212071","volume":"92","author":"ED Chan","year":"2012","unstructured":"Chan ED, Pott GB, Silkoff PE, Ralston AH, Bryan CL, Shapiro L . Alpha-1-antitrypsin inhibits nitric oxide production. J Leukoc Biol 2012; 92: 1251\u20131260.","journal-title":"J Leukoc Biol"},{"key":"BFcmi201417_CR43","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/labinvest.3780324","volume":"81","author":"A Churg","year":"2001","unstructured":"Churg A, Dai J, Zay K, Karsan A, Hendricks R, Yee C et al. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest 2001; 81: 1119\u20131131.","journal-title":"Lab Invest"},{"key":"BFcmi201417_CR44","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1084\/jem.178.5.1629","volume":"178","author":"H Tilg","year":"1993","unstructured":"Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW . Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med 1993; 178: 1629\u20131636.","journal-title":"J Exp Med"},{"key":"BFcmi201417_CR45","doi-asserted-by":"publisher","first-page":"16236","DOI":"10.1073\/pnas.0807627105","volume":"105","author":"EC Lewis","year":"2008","unstructured":"Lewis EC, Mizrahi M, Toledano M, Defelice N, Wright JL, Churg A et al. alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci USA 2008; 105: 16236\u201316241.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201417_CR46","doi-asserted-by":"publisher","first-page":"8602","DOI":"10.1128\/MCB.20.22.8602-8612.2000","volume":"20","author":"J Mendez","year":"2000","unstructured":"Mendez J, Stillman B . Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol Cell Biol 2000; 20: 8602\u20138612.","journal-title":"Mol Cell Biol"},{"key":"BFcmi201417_CR47","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1189\/jlb.0208145","volume":"85","author":"GB Pott","year":"2009","unstructured":"Pott GB, Chan ED, Dinarello CA, Shapiro L . Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol 2009; 85: 886\u2013895.","journal-title":"J Leukoc Biol"},{"key":"BFcmi201417_CR48","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1073\/pnas.1117665109","volume":"109","author":"I Tawara","year":"2012","unstructured":"Tawara I, Sun Y, Lewis EC, Toubai T, Evers R, Nieves E et al. Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 2012; 109: 564\u2013569.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201417_CR49","first-page":"L92","volume":"269","author":"JN Kline","year":"1995","unstructured":"Kline JN, Fisher PA, Monick MM, Hunninghake GW . Regulation of interleukin-1 receptor antagonist by Th1 and Th2 cytokines. Am J Physiol 1995; 269: L92\u2013L98.","journal-title":"Am J Physiol"},{"key":"BFcmi201417_CR50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/cyto.1996.0021","volume":"8","author":"C Marie","year":"1996","unstructured":"Marie C, Pitton C, Fitting C, Cavaillon JM . IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils. Cytokine 1996; 8: 147\u2013151.","journal-title":"Cytokine"},{"key":"BFcmi201417_CR51","first-page":"47","volume":"13","author":"JK Jenkins","year":"1994","unstructured":"Jenkins JK, Malyak M, Arend WP . The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils. Lymphokine Cytokine Res 1994; 13: 47\u201354.","journal-title":"Lymphokine Cytokine Res"},{"key":"BFcmi201417_CR52","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1084\/jem.179.5.1695","volume":"179","author":"MA Cassatella","year":"1994","unstructured":"Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S . Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994; 179: 1695\u20131699.","journal-title":"J Exp Med"},{"key":"BFcmi201417_CR53","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1096\/fj.09-145573","volume":"24","author":"N Tamassia","year":"2010","unstructured":"Tamassia N, Castellucci M, Rossato M, Gasperini S, Bosisio D, Giacomelli M et al. Uncovering an IL-10-dependent NF-kappaB recruitment to the IL-1ra promoter that is impaired in STAT3 functionally defective patients. FASEB J 2010; 24: 1365\u20131375.","journal-title":"FASEB J"},{"key":"BFcmi201417_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11011-011-9239-9","volume":"26","author":"S Subramanian","year":"2011","unstructured":"Subramanian S, Shahaf G, Ozeri E, Miller LM, Vandenbark AA, Lewis EC et al. Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice. Metab Brain Dis 2011; 26: 107\u2013113.","journal-title":"Metab Brain Dis"},{"key":"BFcmi201417_CR55","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4049\/jimmunol.1101340","volume":"189","author":"E Ozeri","year":"2012","unstructured":"Ozeri E, Mizrahi M, Shahaf G, Lewis EC . Alpha-1 antitrypsin promotes semi-mature, interleukin-10-producing and readily migrating tolerogenic dendritic cells. J Immunol 2012; 189: 146\u2013153.","journal-title":"J Immunol"},{"key":"BFcmi201417_CR56","doi-asserted-by":"publisher","first-page":"16242","DOI":"10.1073\/pnas.0808031105","volume":"105","author":"M Koulmanda","year":"2008","unstructured":"Koulmanda M, Bhasin M, Hoffman L, Fan Z, Qipo A, Shi H et al. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci USA 2008; 105: 16242\u201316247.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201417_CR57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1586\/eci.12.33","volume":"8","author":"S Goldstein","year":"2012","unstructured":"Goldstein S, Reddy P . Tolerance without toxicity? alpha1-antitrypsin as a novel alternative to immunosuppression. Expert Rev Clin Immunol 2012; 8: 397\u2013399.","journal-title":"Expert Rev Clin Immunol"},{"key":"BFcmi201417_CR58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1158\/0008-5472.CAN-09-1397","volume":"70","author":"HC Thoms","year":"2010","unstructured":"Thoms HC, Loveridge CJ, Simpson J, Clipson A, Reinhardt K, Dunlop MG et al. Nucleolar targeting of RelAp65 is regulated by COMMD1-dependent ubiquitination. Cancer Res 2010; 70: 139\u2013149.","journal-title":"Cancer Res"},{"key":"BFcmi201417_CR59","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1055\/s-2008-1065206","volume":"115","author":"F Makowiec","year":"1990","unstructured":"Makowiec F, Koveker G, Weber P, Jenss H, Starlinger M . Crohn's disease: disease activity and recurrence following surgery. Deut Med Wochenschr 1990; 115: 1659\u20131664. German.","journal-title":"Deut Med Wochenschr"},{"key":"BFcmi201417_CR60","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00018-011-0912-2","volume":"69","author":"K Hochrainer","year":"2012","unstructured":"Hochrainer K, Racchumi G, Zhang S, Iadecola C, Anrather J . Monoubiquitination of nuclear RelA negatively regulates NF-kappaB activity independent of proteasomal degradation. Cell Mol Life Sci 2012; 69: 2057\u20132073.","journal-title":"Cell Mol Life Sci"},{"key":"BFcmi201417_CR61","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.biocel.2007.02.017","volume":"39","author":"IM Nita","year":"2007","unstructured":"Nita IM, Serapinas D, Janciauskiene SM . alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro. Int J Biochem Cell Biol 2007; 39: 1165\u20131176.","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi201417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201417","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T11:38:26Z","timestamp":1672745906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,7]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["BFcmi201417"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2014.17","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,7]]},"assertion":[{"value":"21 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}